Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID-19 Impact on Lipid Nanoparticles Market
5.1. COVID-19 Landscape: Lipid Nanoparticles Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Lipid Nanoparticles Market, By Type
8.1. Lipid Nanoparticles Market, by Type, 2025-2033
8.1.1 Solid Lipid Nanoparticles (SLNS)
8.1.1.1. Market Revenue and Forecast (2024-2033)
8.1.2. Nanostructured Lipid Carriers (NLCS)
8.1.2.1. Market Revenue and Forecast (2024-2033)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2024-2033)
Chapter 9. Global Lipid Nanoparticles Market, By Application
9.1. Lipid Nanoparticles Market, by Application, 2025-2033
9.1.1. Therapeutics
9.1.1.1. Market Revenue and Forecast (2024-2033)
9.1.2. Research
9.1.2.1. Market Revenue and Forecast (2024-2033)
Chapter 10. Global Lipid Nanoparticles Market, By End-User
10.1. Lipid Nanoparticles Market, by End-User, 2025-2033
10.1.1. Pharmaceutical and Biotechnology Companies
10.1.1.1. Market Revenue and Forecast (2024-2033)
10.1.2. Academic and Research Institutes
10.1.2.1. Market Revenue and Forecast (2024-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2024-2033)
Chapter 11. Global Lipid Nanoparticles Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2024-2033)
11.1.2. Market Revenue and Forecast, by Application (2024-2033)
11.1.3. Market Revenue and Forecast, by End-User (2024-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.1.4.2. Market Revenue and Forecast, by Application (2024-2033)
11.1.4.3. Market Revenue and Forecast, by End-User (2024-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.1.5.2. Market Revenue and Forecast, by Application (2024-2033)
11.1.5.3. Market Revenue and Forecast, by End-User (2024-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.2. Market Revenue and Forecast, by Application (2024-2033)
11.2.3. Market Revenue and Forecast, by End-User (2024-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.4.2. Market Revenue and Forecast, by Application (2024-2033)
11.2.4.3. Market Revenue and Forecast, by End-User (2024-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.5.2. Market Revenue and Forecast, by Application (2024-2033)
11.2.5.3. Market Revenue and Forecast, by End-User (2024-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.6.2. Market Revenue and Forecast, by Application (2024-2033)
11.2.6.3. Market Revenue and Forecast, by End-User (2024-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.7.2. Market Revenue and Forecast, by Application (2024-2033)
11.2.7.3. Market Revenue and Forecast, by End-User (2024-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.2. Market Revenue and Forecast, by Application (2024-2033)
11.3.3. Market Revenue and Forecast, by End-User (2024-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.4.2. Market Revenue and Forecast, by Application (2024-2033)
11.3.4.3. Market Revenue and Forecast, by End-User (2024-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.5.2. Market Revenue and Forecast, by Application (2024-2033)
11.3.5.3. Market Revenue and Forecast, by End-User (2024-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.6.2. Market Revenue and Forecast, by Application (2024-2033)
11.3.6.3. Market Revenue and Forecast, by End-User (2024-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.7.2. Market Revenue and Forecast, by Application (2024-2033)
11.3.7.3. Market Revenue and Forecast, by End-User (2024-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.2. Market Revenue and Forecast, by Application (2024-2033)
11.4.3. Market Revenue and Forecast, by End-User (2024-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.4.2. Market Revenue and Forecast, by Application (2024-2033)
11.4.4.3. Market Revenue and Forecast, by End-User (2024-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.5.2. Market Revenue and Forecast, by Application (2024-2033)
11.4.5.3. Market Revenue and Forecast, by End-User (2024-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.6.2. Market Revenue and Forecast, by Application (2024-2033)
11.4.6.3. Market Revenue and Forecast, by End-User (2024-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.7.2. Market Revenue and Forecast, by Application (2024-2033)
11.4.7.3. Market Revenue and Forecast, by End-User (2024-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.5.2. Market Revenue and Forecast, by Application (2024-2033)
11.5.3. Market Revenue and Forecast, by End-User (2024-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.5.4.2. Market Revenue and Forecast, by Application (2024-2033)
11.5.4.3. Market Revenue and Forecast, by End-User (2024-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.5.5.2. Market Revenue and Forecast, by Application (2024-2033)
11.5.5.3. Market Revenue and Forecast, by End-User (2024-2033)
Chapter 12. Company Profiles
12.1. Acuitas Therapeutics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Alnylam Pharmaceuticals
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amgen Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Arbutus Biopharma
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Arcturus Therapeutics
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Arranta Bio
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Avanti Polar Lipids
12.8. BioNTech SE
12.9. CordenPharma International
12.10. Dicerna Pharmaceuticals
12.11. Evonik Industries AG
12.12. Exelead
12.13. Gattefossé
12.14. Genevant Sciences
12.15. Helix Biotech, Inc.
12.16. IOI Oleo GmbH
12.17. Lipoid GmbH
12.18. Merck KGaA
12.19. Moderna, Inc.
12.20. Pfizer Inc.
12.21. Precision NanoSystems Inc.
12.22. Sanofi SA
12.23. Sirnaomics
12.24. Wacker Chemie AG
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます
